Fort Worth, Texas-based Rhino Health, the only manufacturer of nitrile gloves in the United States, received $58 million to expand its facilities in south Fort Worth. The company received the funding from New Markets Tax Credit with capital from five c…
The FDA cleared the way for Bavarian Nordic, the world’s only vaccine-maker with an authorized monkeypox vaccine, to manufacture more supply after authorizing its Denmark facility July 27.
Nearly 800,000 additional monkeypox vaccine doses will soon be available for distribution to states and jurisdictions, healthcare leaders said during a July 28 HHS news conference.
Pfizer’s Paxlovid beat Merck’s COVID-19 antiviral treatment in sales in May, but the boom in demand is slowing down as less than half of Pfizer’s production capacity has been sold, according to data surveillance company Airfinity.
Supply chain developments reported by Becker’s since July 21:
The state with the most monkeypox cases, New York, only had 1,000 monkeypox vaccines while the U.S. had 372,000 doses waiting overseas, The New York Times reported July 25.
The world’s only company with an authorized monkeypox vaccine, Bavarian Nordic, may soon be running 24/7 after the World Health Organization defined the current outbreak as a global health emergency, according to Bloomberg.
Material science company 3M said it plans to spin off its healthcare ventures into two publicly traded companies, New 3M and Health Care, by the end of 2023.
There aren’t enough monkeypox vaccines to go around.
Healthcare investment firm Patient Square Capital plans to acquire Hanger, an Austin, Texas-based orthotic and prosthetic devicemaker, for $1.25 billion.
